|
|
||||||||
Infectious Disease Research Laboratory, Stratton Veterans Affairs Medical Center1 , and Albany Medical College2 , Albany, NY 12208, USA
Correspondence
Aldona L. Baltch
aldona.baltch{at}med.va.gov
Received 1 November 2005
Accepted 22 March 2006
2.5x MIC (P<0.05). The data show that intracellular growth and survival of these Candida species in the absence or presence of voriconazole vary markedly. The activity of voriconazole depends on the concentration of the drug and the time of exposure. For the 12 Candida strains studied, regression curves show that the maximum intracellular anticandidal activity of voriconazole was reached at 3.55x MIC.
Abbreviations: MDM, human monocyte-derived macrophage.
This article has been cited by other articles:
![]() |
M. Simitsopoulou, E. Roilides, F. Paliogianni, C. Likartsis, J. Ioannidis, K. Kanellou, and T. J. Walsh Immunomodulatory Effects of Voriconazole on Monocytes Challenged with Aspergillus fumigatus: Differential Role of Toll-Like Receptors Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3301 - 3306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Simitsopoulou, E. Roilides, C. Likartsis, J. Ioannidis, A. Orfanou, F. Paliogianni, and T. J. Walsh Expression of Immunomodulatory Genes in Human Monocytes Induced by Voriconazole in the Presence of Aspergillus fumigatus Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1048 - 1054. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |